id	sid	eid	entity	type
ajlm-1264	1	1	university of zimbabwe college of health sciences	ORG
ajlm-1264	1	2	harare	GPE
ajlm-1264	1	3	zimbabwe	GPE
ajlm-1264	1	4	anthony t. podany	PERSON
ajlm-1264	1	5	university of nebraska medical center	ORG
ajlm-1264	1	6	omaha	GPE
ajlm-1264	1	7	nebraska	GPE
ajlm-1264	1	8	united states	GPE
ajlm-1264	1	9	timothy mykris	PERSON
ajlm-1264	1	10	university of nebraska medical center	ORG
ajlm-1264	1	11	omaha	GPE
ajlm-1264	1	12	nebraska	GPE
ajlm-1264	1	13	united states	ORG
ajlm-1264	1	14	farai muzambi international pharmacology specialty laboratory	ORG
ajlm-1264	1	15	university of zimbabwe college of health sciences	ORG
ajlm-1264	1	16	harare	GPE
ajlm-1264	1	17	zimbabwe	GPE
ajlm-1264	1	18	richard w. browne	PERSON
ajlm-1264	1	19	buffalo	GPE
ajlm-1264	1	20	buffalo	GPE
ajlm-1264	1	21	new york	GPE
ajlm-1264	1	22	united states	ORG
ajlm-1264	1	23	andrew j. ocque	PERSON
ajlm-1264	1	24	buffalo	GPE
ajlm-1264	1	25	buffalo	GPE
ajlm-1264	1	26	new york	GPE
ajlm-1264	1	27	united states	GPE
ajlm-1264	1	28	robin difrancesco	PERSON
ajlm-1264	1	29	buffalo	GPE
ajlm-1264	1	30	buffalo	GPE
ajlm-1264	1	31	new york	GPE
ajlm-1264	1	32	united states	GPE
ajlm-1264	1	33	lee c. winchester	PERSON
ajlm-1264	1	34	university of nebraska medical center	ORG
ajlm-1264	1	35	omaha	GPE
ajlm-1264	1	36	nebraska	GPE
ajlm-1264	1	37	united states	ORG
ajlm-1264	1	38	courtney v. fletcher	PERSON
ajlm-1264	1	39	university of nebraska medical center	ORG
ajlm-1264	1	40	omaha	GPE
ajlm-1264	1	41	nebraska	GPE
ajlm-1264	1	42	united states tinashe mudzviti international pharmacology specialty laboratory	ORG
ajlm-1264	1	43	university of zimbabwe college of health sciences	ORG
ajlm-1264	1	44	harare	GPE
ajlm-1264	1	45	zimbabwe	GPE
ajlm-1264	1	46	charles c. maponga	PERSON
ajlm-1264	1	47	university of zimbabwe college of health sciences	ORG
ajlm-1264	1	48	harare	GPE
ajlm-1264	1	49	zimbabwe	GPE
ajlm-1264	1	50	buffalo	GPE
ajlm-1264	1	51	buffalo	GPE
ajlm-1264	1	52	new york	GPE
ajlm-1264	1	53	united states	GPE
ajlm-1264	1	54	buffalo	GPE
ajlm-1264	1	55	buffalo	GPE
ajlm-1264	1	56	new york	GPE
ajlm-1264	1	57	united states	ORG
ajlm-1264	3	1	zimbabwe	GPE
ajlm-1264	4	1	afr j	PERSON
ajlm-1264	5	1	2021;10(1	CARDINAL
ajlm-1264	6	1	zimbabwe	GPE
ajlm-1264	6	2	makita-chingombe	ORG
ajlm-1264	6	3	anthony t. podany	PERSON
ajlm-1264	6	4	timothy mykris	PERSON
ajlm-1264	6	5	farai muzambi	ORG
ajlm-1264	6	6	richard w. browne	PERSON
ajlm-1264	6	7	andrew j. ocque	PERSON
ajlm-1264	6	8	robin difrancesco	PERSON
ajlm-1264	6	9	lee c. winchester	PERSON
ajlm-1264	6	10	courtney v. fletcher	PERSON
ajlm-1264	6	11	tinashe mudzviti	PERSON
ajlm-1264	6	12	charles c. maponga	PERSON
ajlm-1264	6	13	gene d. morse	PERSON
ajlm-1264	6	14	08	CARDINAL
ajlm-1264	6	15	24 feb. 2021	DATE
ajlm-1264	6	16	08 july 2021	DATE
ajlm-1264	6	17	2021	CARDINAL
ajlm-1264	10	1	the university of zimbabwe	ORG
ajlm-1264	11	1	5279	DATE
ajlm-1264	11	2	the university of nebraska	ORG
ajlm-1264	11	3	psl	ORG
ajlm-1264	11	4	the university of zimbabwe psl	ORG
ajlm-1264	13	1	eighty-seven percent	PERCENT
ajlm-1264	13	2	± 20%	PERCENT
ajlm-1264	15	1	the university of zimbabwe	ORG
ajlm-1264	17	1	the nevirapine bioanalytics method2	ORG
ajlm-1264	17	2	separation.3,4,5	PRODUCT
ajlm-1264	17	3	two	CARDINAL
ajlm-1264	17	4	the united states	GPE
ajlm-1264	17	5	university of nebraska medical center pharmacology specialty laboratory	ORG
ajlm-1264	17	6	unmc-psl	PRODUCT
ajlm-1264	18	1	unmc-psl	PRODUCT
ajlm-1264	18	2	5279	DATE
ajlm-1264	19	1	unmc-psl	ORG
ajlm-1264	24	1	95	CARDINAL
ajlm-1264	24	2	the uz college of health sciences clinical trial research center	ORG
ajlm-1264	24	3	nevirapine assays	ORG
ajlm-1264	24	4	unmc-psl	PRODUCT
ajlm-1264	25	1	nevirapine pharmacokinetics	ORG
ajlm-1264	28	1	1	CARDINAL
ajlm-1264	28	2	1200	CARDINAL
ajlm-1264	28	3	10 min	QUANTITY
ajlm-1264	28	4	4 °	QUANTITY
ajlm-1264	29	1	70 °	QUANTITY
ajlm-1264	29	2	unmc-psl	PRODUCT
ajlm-1264	31	1	university of nebraska	ORG
ajlm-1264	31	2	psl nevirapine	PERSON
ajlm-1264	31	3	unmc-psl	PRODUCT
ajlm-1264	32	1	unmc-psl	PRODUCT
ajlm-1264	32	2	25 ng/ml	QUANTITY
ajlm-1264	32	3	10 000 ng/ml	QUANTITY
ajlm-1264	35	1	unmc-psl	ORG
ajlm-1264	35	2	2489	CARDINAL
ajlm-1264	35	3	milford	GPE
ajlm-1264	35	4	massachusetts	GPE
ajlm-1264	35	5	united states	GPE
ajlm-1264	35	6	2	CARDINAL
ajlm-1264	35	7	milford	GPE
ajlm-1264	35	8	massachusetts	GPE
ajlm-1264	35	9	united states	GPE
ajlm-1264	36	1	the united states food and drug	GPE
ajlm-1264	36	2	university of zimbabwe international	ORG
ajlm-1264	36	3	psl nevirapine	PERSON
ajlm-1264	36	4	95	CARDINAL
ajlm-1264	37	1	5.8	CARDINAL
ajlm-1264	37	2	kyoto	GPE
ajlm-1264	37	3	japan	GPE
ajlm-1264	38	1	500 ng	QUANTITY
ajlm-1264	38	2	15 000 ng/ml	QUANTITY
ajlm-1264	40	1	united states food and drug administration	ORG
ajlm-1264	42	1	over five	CARDINAL
ajlm-1264	42	2	two	CARDINAL
ajlm-1264	42	3	brookline	GPE
ajlm-1264	42	4	massachusetts	GPE
ajlm-1264	42	5	united states	GPE
ajlm-1264	44	1	unmc-psl	PRODUCT
ajlm-1264	46	1	2	CARDINAL
ajlm-1264	46	2	8.3	CARDINAL
ajlm-1264	46	3	san diego	GPE
ajlm-1264	46	4	california	GPE
ajlm-1264	46	5	united states	GPE
ajlm-1264	47	1	ninety-five	CARDINAL
ajlm-1264	48	1	34 000 ng/ml	QUANTITY
ajlm-1264	51	1	97%	PERCENT
ajlm-1264	51	2	between 2000 ng/ml and	QUANTITY
ajlm-1264	51	3	20 000 ng/ml	QUANTITY
ajlm-1264	51	4	3%	PERCENT
ajlm-1264	51	5	3	CARDINAL
ajlm-1264	51	6	20 000 ng/ml	QUANTITY
ajlm-1264	51	7	1	CARDINAL
ajlm-1264	51	8	1a)9	CARDINAL
ajlm-1264	52	1	15 000 ng/ml	QUANTITY
ajlm-1264	53	1	15 000 ng/ml	QUANTITY
ajlm-1264	53	2	5086 ng/ml	QUANTITY
ajlm-1264	53	3	13 368 ng/ml	QUANTITY
ajlm-1264	53	4	19.1	CARDINAL
ajlm-1264	53	5	50.2	CARDINAL
ajlm-1264	53	6	93%	PERCENT
ajlm-1264	53	7	15 000 ng/ml	QUANTITY
ajlm-1264	53	8	1)9	CARDINAL
ajlm-1264	53	9	7%	PERCENT
ajlm-1264	54	1	seven	CARDINAL
ajlm-1264	55	1	grubbs	PERSON
ajlm-1264	56	1	1	CARDINAL
ajlm-1264	56	2	unmc-psl	FAC
ajlm-1264	56	3	omaha	GPE
ajlm-1264	56	4	nebraska	GPE
ajlm-1264	56	5	united states	GPE
ajlm-1264	56	6	october 2017	DATE
ajlm-1264	56	7	harare	GPE
ajlm-1264	56	8	zimbabwe	GPE
ajlm-1264	56	9	may 2018	DATE
ajlm-1264	56	10	95	CARDINAL
ajlm-1264	57	1	87	CARDINAL
ajlm-1264	59	1	1	CARDINAL
ajlm-1264	59	2	nevirapine assay	ORG
ajlm-1264	59	3	the university of zimbabwe international hiv pharmacology specialty laboratory	ORG
ajlm-1264	59	4	harare	GPE
ajlm-1264	59	5	zimbabwe	GPE
ajlm-1264	59	6	may 2018	DATE
ajlm-1264	59	7	the university of nebraska medical center pharmacology specialty laboratory	ORG
ajlm-1264	59	8	omaha	GPE
ajlm-1264	59	9	nebraska	GPE
ajlm-1264	59	10	united states	GPE
ajlm-1264	59	11	october	DATE
ajlm-1264	59	12	2017	DATE
ajlm-1264	60	1	two	CARDINAL
ajlm-1264	60	2	1)9	CARDINAL
ajlm-1264	60	3	3%	PERCENT
ajlm-1264	60	4	4%	PERCENT
ajlm-1264	60	5	unmc-psl	PERSON
ajlm-1264	61	1	the deming regression analysis	ORG
ajlm-1264	61	2	1b)9	CARDINAL
ajlm-1264	62	1	2a9	CARDINAL
ajlm-1264	63	1	2b)9	CARDINAL
ajlm-1264	64	1	2	CARDINAL
ajlm-1264	64	2	nevirapine	GPE
ajlm-1264	64	3	unmc-psl	ORG
ajlm-1264	64	4	omaha	GPE
ajlm-1264	64	5	nebraska	GPE
ajlm-1264	64	6	united states	GPE
ajlm-1264	64	7	october 2017	DATE
ajlm-1264	64	8	harare	GPE
ajlm-1264	64	9	zimbabwe	GPE
ajlm-1264	64	10	may 2018	DATE
ajlm-1264	68	1	5740	DATE
ajlm-1264	68	2	5000–7440	CARDINAL
ajlm-1264	68	3	3730 ng/ml	QUANTITY
ajlm-1264	68	4	3200–5080)8	CARDINAL
ajlm-1264	69	1	two	CARDINAL
ajlm-1264	70	1	unmc-psl	PRODUCT
ajlm-1264	71	1	the united states food and drug administration	ORG
ajlm-1264	72	1	about 20%	PERCENT
ajlm-1264	75	1	4%	PERCENT
ajlm-1264	75	2	19%	PERCENT
ajlm-1264	77	1	one	CARDINAL
ajlm-1264	77	2	two	CARDINAL
ajlm-1264	79	1	20 000 ng/ml	QUANTITY
ajlm-1264	80	1	psl	PERSON
ajlm-1264	83	1	dr marshall munjoma	PERSON
ajlm-1264	85	1	f.m.	ORG
ajlm-1264	88	1	psl	PERSON
ajlm-1264	89	1	l.c.w	PERSON
ajlm-1264	90	1	r.w.b.	GPE
ajlm-1264	90	2	r.d.	GPE
ajlm-1264	92	1	university of zimbabwe	ORG
ajlm-1264	92	2	the united states	GPE
ajlm-1264	92	3	national institute of allergy	ORG
ajlm-1264	92	4	5um1ai106701-04	CARDINAL
ajlm-1264	93	1	university of nebraska	ORG
ajlm-1264	93	2	psl	PRODUCT
ajlm-1264	93	3	the united states	GPE
ajlm-1264	93	4	national institute of allergy	ORG
ajlm-1264	93	5	atp (k23 ai134307	ORG
ajlm-1264	94	1	the united states	GPE
ajlm-1264	94	2	national institute of allergy	ORG
ajlm-1264	94	3	hhsn272200800019c	PRODUCT
ajlm-1264	95	1	the university of rochester center for aids research	ORG
ajlm-1264	95	2	united states national institutes of health	ORG
ajlm-1264	96	1	1	CARDINAL
ajlm-1264	96	2	buffalo	GPE
ajlm-1264	96	3	university of new york	ORG
ajlm-1264	96	4	buffalo	GPE
ajlm-1264	96	5	new york	GPE
ajlm-1264	96	6	united states	GPE
ajlm-1264	96	7	2	CARDINAL
ajlm-1264	96	8	university of zimbabwe college of health sciences	ORG
ajlm-1264	96	9	a178	GPE
ajlm-1264	96	10	avondale	GPE
ajlm-1264	96	11	harare	GPE
ajlm-1264	96	12	zimbabwe	GPE
ajlm-1264	96	13	3	CARDINAL
ajlm-1264	96	14	university of nebraska medical center	ORG
ajlm-1264	96	15	omaha	GPE
ajlm-1264	96	16	nebraska	GPE
ajlm-1264	96	17	united states	GPE
ajlm-1264	97	1	the united states	GPE
ajlm-1264	98	1	mtisi tj	PERSON
ajlm-1264	98	2	maponga	GPE
ajlm-1264	98	3	monera-penduka tg	ORG
ajlm-1264	100	1	afr j	PERSON
ajlm-1264	100	2	2018;7(1):a659	TIME
ajlm-1264	101	1	ocque aj	PERSON
ajlm-1264	101	2	difrancesco r	PERSON
ajlm-1264	102	1	afr j	PERSON
ajlm-1264	103	1	2019;8(1):a880	CARDINAL
ajlm-1264	104	1	bolaris ma	PERSON
ajlm-1264	104	2	keller ma	PERSON
ajlm-1264	104	3	robbins bl	PERSON
ajlm-1264	104	4	fletcher cv	PERSON
ajlm-1264	104	5	3	CARDINAL
ajlm-1264	106	1	2017	CARDINAL
ajlm-1264	107	1	korpalski	PERSON
ajlm-1264	110	1	1999;20(1–2):91–98	CARDINAL
ajlm-1264	111	1	liu z	PERSON
ajlm-1264	111	2	chou m	PERSON
ajlm-1264	112	1	antimicrob	PERSON
ajlm-1264	114	1	https://doi.org/10.1128/aac.02294-12 swindells s	PERSON
ajlm-1264	114	2	ramchandani r	PERSON
ajlm-1264	114	3	gupta	GPE
ajlm-1264	115	1	one month	DATE
ajlm-1264	118	1	httrps://doi.org/10.1056/nejmoa1806808 united states	GPE
ajlm-1264	118	2	food and drug administration	ORG
ajlm-1264	120	1	rockville	GPE
ajlm-1264	120	2	md	GPE
ajlm-1264	120	3	fda	ORG
ajlm-1264	120	4	2001	DATE
ajlm-1264	121	1	nevirapine pk	PERSON
ajlm-1264	122	1	2016	DATE
ajlm-1264	123	1	2020	DATE
ajlm-1264	125	1	2019	DATE
ajlm-1264	126	1	nevirapine comparison	PERSON